AI Article Synopsis

Article Abstract

Fournier's gangrene is a severe type of necrotizing fasciitis that affects the perineal and genital regions. Because of its rapid progression, Fournier's gangrene is associated with high mortality and morbidity rates. Surgical treatment of Fournier's gangrene requires leaving the wound open and performing multiple debridement procedures. We report a case of Fournier's gangrene caused by in a 9-year-old boy with severe autism. Because of the patient's condition, surgical treatment included thorough debridement and closure of the initial wound under general anesthesia. This case was successfully treated and the patient was discharged without infection recurrence.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11490670PMC
http://dx.doi.org/10.1016/j.eucr.2024.102860DOI Listing

Publication Analysis

Top Keywords

fournier's gangrene
20
closure initial
8
case fournier's
8
surgical treatment
8
fournier's
5
gangrene
5
initial surgical
4
surgical wound
4
wound successful
4
successful treatment
4

Similar Publications

Objectives: Fournier's gangrene is an aggressive, rapidly progressing, and life-threatening necrotizing fasciitis of the perineal and genital regions. Various scoring systems have been developed for predicting survival and prognosis in Fournier's gangrene. This retrospective study aimed to evaluate the effectiveness of the newly developed Fournier's gangrene mortality index (FGMI) in predicting mortality associated with Fournier's gangrene.

View Article and Find Full Text PDF

Introduction: Fournier's gangrene, a polymicrobial infection affecting the scrotum and perineal area, predominantly affects elderly males, presenting challenges in diagnosis and management. This report examines two cases, with a focus on the rare outcome of bilateral orchidectomy.

Case Presentation: A 69-year-old diabetic male presented with severe penile and scrotal pain, leading to the diagnosis of Fournier's gangrene.

View Article and Find Full Text PDF
Article Synopsis
  • - SGLT2 inhibitors block transporters in the kidneys, which increases sodium and glucose excretion, leading to lower blood sugar levels, improved blood pressure, and weight loss.
  • - These medications have shown protective effects for the heart and kidneys, reducing the risk of cardiovascular death, hospitalization due to heart failure, and progression to advanced kidney disease.
  • - While SGLT2 inhibitors are generally safe and do not raise the risk of low blood sugar or acute kidney injury, they can lead to rare but serious side effects, like normoglycemic ketoacidosis and Fournier's gangrene, that require medical awareness.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!